Compound and an organic semiconducting layer, an organic electronic device, a display device and a lighting device comprising the same
US-2024132468-A1 · Apr 25, 2024 · US
US9975860B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9975860-B2 |
| Application number | US-201515111865-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jan 15, 2015 |
| Priority date | Jan 17, 2014 |
| Publication date | May 22, 2018 |
| Grant date | May 22, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds and compositions are described which are useful especially for treatment of angiogenesis-related diseases or disorders such as neovascularisation of the eye, age-related macular degeneration, diabetic retinopathy or cancer.
Opening claim text (preview).
The invention claimed is: 1. A method for the treatment of an angiogenesis related disease or disorder comprising the step of administering a compound of the formula or a salt thereof. 2. The method as claimed in claim 1 , wherein the angiogenesis-related disease or disorder is associated with neovascularisation of the eye. 3. The method as claimed in claim 1 , wherein the angiogenesis-related disease or disorder is associated with blindness. 4. The method as claimed in claim 1 , wherein the angiogenesis-related disease or disorder is age-related macular degeneration or diabetic retinopathy. 5. The method as claimed in claim 4 , wherein the age-related macular degeneration is wet age-related macular degeneration. 6. The method as claimed in claim 1 , wherein the angiogenesis-related disease or disorder is cancer. 7. The method as claimed in claim 6 , wherein the cancer is a solid tumour forming cancer. 8. The method as claimed in claim 6 , wherein the cancer is colorectal cancer. 9. The method as claimed in claim 6 , wherein the cancer is oesophageal cancer. 10. The method as claimed in claim 6 , wherein the cancer is breast cancer.
Antineoplastic agents · CPC title
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title
with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title
linked by a carbon chain containing only aliphatic carbon atoms · CPC title
Ophthalmic agents · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.